These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8481213)

  • 21. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
    Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
    Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of a long acting luteinizing hormone releasing hormone agonist (Decapeptyl) and orchiectomy in the treatment of advanced prostatic cancer. Preliminary report.
    De Sy WA; de Meyer JM; Casselman J; De Smet R; Renders G; Schelfhout W; De Wilde P
    Acta Urol Belg; 1986; 54(2):221-9. PubMed ID: 2942015
    [No Abstract]   [Full Text] [Related]  

  • 23. [GnRH analogues and myomas: which strategy?].
    Poncelet C
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1018. PubMed ID: 16316770
    [No Abstract]   [Full Text] [Related]  

  • 24. [Analogs of gonadoliberin. Value in physiology and therapeutics].
    Charbonnel B
    Presse Med; 1994 Apr 30-May 7; 23(17):805-11. PubMed ID: 8078839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pubertal development in the male pig: effects of treatment with a long-acting gonadotropin-releasing hormone agonist on plasma luteinizing hormone, follicle stimulating hormone and testosterone.
    Trudeau VL; Meijer JC; Erkens JH; van de Wiel DF; Wensing CJ
    Can J Vet Res; 1992 Apr; 56(2):102-9. PubMed ID: 1534270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A gonadotropin-releasing hormone (GnRH) receptor specific for GnRH II in primates.
    Neill JD; Duck LW; Sellers JC; Musgrove LC
    Biochem Biophys Res Commun; 2001 Apr; 282(4):1012-8. PubMed ID: 11352653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide.
    Rittmaster RS
    J Clin Endocrinol Metab; 1988 Oct; 67(4):651-5. PubMed ID: 3138274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadotropin gene expression and secretion in gonadotropin-releasing hormone antagonist-treated male rats: effect of sex steroid replacement.
    Perheentupa A; Huhtaniemi I
    Endocrinology; 1990 Jun; 126(6):3204-9. PubMed ID: 1693570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral immune responses against gonadotropin releasing hormone elicited by immunization with phage-peptide constructs obtained via phage display.
    Samoylov A; Cochran A; Schemera B; Kutzler M; Donovan C; Petrenko V; Bartol F; Samoylova T
    J Biotechnol; 2015 Dec; 216():20-8. PubMed ID: 26456116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues.
    Rahimipour S; Ben-Aroya N; Ziv K; Chen A; Fridkin M; Koch Y
    J Med Chem; 2003 Sep; 46(19):3965-74. PubMed ID: 12954050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of new testosterone transdermal therapeutic systems in gonadotropin-releasing hormone antagonist-suppressed normal men.
    Rolf C; Gottschalk I; Behre HM; Rauch C; Thyroff U; Nieschlag E
    Exp Clin Endocrinol Diabetes; 1999; 107(1):63-9. PubMed ID: 10077358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo.
    Khan MA; Ferro VA; Koyama S; Kinugasa Y; Song M; Ogita K; Tsutsui T; Murata Y; Kimura T
    Vaccine; 2007 May; 25(18):3544-53. PubMed ID: 17316929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [GnRH antagonists--a new therapy option for advanced prostate cancer].
    Wolff JM
    Aktuelle Urol; 2009 May; 40(3):159-63. PubMed ID: 19399720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between gonadotrophin-releasing hormone analogue therapy and bone loss; a review.
    Fraser IS
    Reprod Fertil Dev; 1991; 3(1):61-9. PubMed ID: 1957015
    [No Abstract]   [Full Text] [Related]  

  • 35. Normal adults and subjects with hypogonadotropic hypogonadism respond differently to D-Ser(TBU)6-LH-RH-EA10.
    Smith R; Donald RA; Espiner EA; Stronach SG; Edwards IA
    J Clin Endocrinol Metab; 1979 Jan; 48(1):167-70. PubMed ID: 106067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of pituitary gonadotropin-releasing hormone receptors by pulsatile gonadotropin-releasing hormone injections in male rats. Modulation by testosterone.
    Garcia A; Schiff M; Marshall JC
    J Clin Invest; 1984 Sep; 74(3):920-8. PubMed ID: 6088587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gonadotropin-releasing hormone agonist and estrogen-progestogen replacement therapy.
    Gudmundsson J; Coutts JR; Fleming R
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 1):1156-7. PubMed ID: 1951529
    [No Abstract]   [Full Text] [Related]  

  • 38. LHRH analogues and bone loss.
    Devogelaer JP; Nagant de Deuxchaisnes C; Donnez J; Thomas K
    Lancet; 1987 Jun; 1(8548):1498. PubMed ID: 2885493
    [No Abstract]   [Full Text] [Related]  

  • 39. Pituitary apoplexy following the administration of gonadotrophin releasing hormone.
    Korsić M
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):696-7. PubMed ID: 7828363
    [No Abstract]   [Full Text] [Related]  

  • 40. Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.
    Plosker GL; Brogden RN
    Drugs; 1994 Dec; 48(6):930-67. PubMed ID: 7533699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.